[May 26, 2016] |
|
Global Head and Neck Cancer Pipeline Report 2016 - Therapeutics Pipeline Review of 150+ Companies & Drug Profiles - Research and Markets
Research and Markets has announced the addition of the "Head
and neck Cancer - Pipeline Review, H1 2016" report to their
offering.
This report provides comprehensive information on the therapeutic
development for Head and Neck Cancer , complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Head and Neck Cancer and special features on late-stage and discontinued
projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
Head and Neck Cancer Overview
-
Therapeutics Development
-
Pipeline Products for Head and Neck Cancer - Overview
-
Pipeline Products for Head and Neck Cancer - Comparative Analysis
-
Head and Neck Cancer - Therapeutics under Development by Companies
-
Head and Neck Cancer - Therapeutics under Investigation by
Universities/Institutes
-
Head and Neck Cancer Products Glance
-
Late Stage Products
-
Clinical Stage Products
-
Early Stage Products
-
Head and Neck Cancer - Products under Development by Companies
-
Head and Neck Cancer - Products under Investigation by
Universities/Institutes
-
Head and Neck Cancer - Companies Involved in Therapeutics Development
-
4SC AG
-
AB Science SA
-
AbbVie Inc.
-
Acceleron Pharma, Inc.
-
Advaxis, Inc.
-
Alchemia Limited
-
Altor BioScience Corporation
-
Ambrx, Inc.
-
Amgen Inc.
-
ANP Technologies, Inc.
-
arGEN-X BV
-
ArQule, Inc.
-
Astellas Pharma Inc.
-
AstraZeneca Plc
-
Atara Biotherapeutics, Inc.
-
ATLAB Pharma SAS (News - Alert)
-
AVEO Pharmaceuticals, Inc.
-
Bayer AG
-
Betta Pharmaceuticals Co. Ltd.
-
Bexion Pharmaceuticals, LLC.
-
Bio-Path Holdings, Inc.
-
BioDiem Ltd
-
Biomics Biotechnologies Co., Ltd.
-
Bionovis SA
-
Biotest AG
-
Boehringer Ingelheim GmbH
-
Boston Biomedical, Inc.
-
Bristol-Myers Squibb Company
-
CEL-SCI Corporation
-
Celgene Corporation
-
Cell Medica Limited
-
Cellceutix Corporation
-
Celldex Therapeutics, Inc.
-
Celltrion, Inc.
-
Centrose LLC
For more information visit http://www.researchandmarkets.com/research/4l5k3t/head_and_neck
View source version on businesswire.com: http://www.businesswire.com/news/home/20160526006186/en/
[ Back To TMCnet.com's Homepage ]
|